Is My Size, Inc. overvalued or undervalued?

As of 15 August 2022, the valuation grade for My Size, Inc. moved from does not qualify to risky, indicating a significant deterioration in its financial standing. The company appears to be overvalued, particularly given its negative performance metrics. Key ratios include a Price to Book Value of 0.65, an EV to EBIT of -0.13, and an EV to EBITDA of -0.15, all suggesting severe financial distress.
In comparison to peers, My Size, Inc. has a P/E ratio of -1.658 and an EV to EBITDA of -0.1658, highlighting its struggles relative to the industry. Notably, the company has experienced a staggering year-to-date return of -72.72%, while the S&P 500 has gained 12.22% in the same period, further emphasizing its underperformance and reinforcing the overvaluation narrative.